3861 results for «2601»

Filter By

3861 results

New devices for structural interventions

21 May 2025 – From EuroPCR 2025

Discover emerging devices transforming structural heart interventions. This session highlights biomimetic valve designs, new transcatheter aortic valve systems, novel devices for aortic insufficiency, leaflet resection, left atrial appendage closure, and short self-expanding TAVR valves with promising early results.

New devices for structural interventions

DCB PCI: are we ready for complex de novo lesions?

21 May 2025 – From EuroPCR 2025

Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...

DCB PCI: are we ready for complex de novo lesions?

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

21 May 2025 – From EuroPCR 2025

Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

Management of non-culprit lesions in patients with ACS and multivessel disease

21 May 2025 – From EuroPCR 2025

This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...

Management of non-culprit lesions in patients with ACS and multivessel disease

TAVI in challenging cases: pushing the limits

21 May 2025 – From EuroPCR 2025

Navigate challenging TAVI cases with this focused session emphasizing valve-in-valve procedures in complex anatomical scenarios. Learn strategies for managing TAVI in patients with multivessel disease and impaired ventricular function, and optimize procedural planning using advanced imaging, access methods, and device selection through detailed case presentations and...

TAVI in challenging cases: pushing the limits

Novel tools and strategies in chronic heart failure

21 May 2025 – From EuroPCR 2025

Discover novel tools and therapeutic strategies in chronic heart failure management. This session presents early clinical experiences with innovative devices such as a chronically-adjustable pressure sensing interatrial shunt, synchronized diaphragmatic stimulation, high-flow pLVADs for cardiogenic shock, and renal artery denervation. Additionally, it reviews the impact of...

Novel tools and strategies in chronic heart failure

CTO, modern challenges and solutions

21 May 2025 – From EuroPCR 2025

Address modern challenges in chronic total occlusion (CTO) interventions with this session focusing on the latest technologies and techniques. Learn key procedural strategies and best practices through detailed case studies, and understand how evolving technology is shaping the future of CTO revascularization.

CTO, modern challenges and solutions

Multi-modality assessment of coronary disease

21 May 2025 – From EuroPCR 2025

This session offers comprehensive multi-modality assessment of coronary disease, integrating advanced imaging and functional testing. Topics include diagnostic yield of OCT and cardiac MRI for MINOCA, transitioning coronary plaque vulnerability assessment from invasive to non-invasive methods, relationships between QFR and IVUS post-PCI in complex lesions, combined...

Multi-modality assessment of coronary disease

New evidence in the PFO closure

21 May 2025 – From EuroPCR 2025

Gain new insights into patent foramen ovale (PFO) closure with this session exploring age-related outcomes, risk of atrial arrhythmia, and patient selection improvements. Review various imaging approaches for assessing residual shunts and compare guidance techniques including TEE, fluoroscopy, and intracardiac echo from recent clinical registries.

New evidence in the PFO closure

New tools for left main treatment

21 May 2025 – From EuroPCR 2025

Examine new tools and strategies tailored for left main coronary artery treatment. This session covers real-world data on intracoronary imaging guidance, post-PCI FFR assessment following provisional T stenting, safety and efficacy of intravascular lithotripsy for calcified left main disease, drug-coated balloon (DCB) treatments for true bifurcation...

New tools for left main treatment

More on long-term responsiveness and effectiveness of renal denervation

21 May 2025 – From EuroPCR 2025

This session presents comprehensive data on the long-term responsiveness and effectiveness of renal denervation. Topics include outcomes in patients with chronic kidney disease, arterial stiffness correlations, safety profiles over nine years, and economic evaluations across European healthcare systems.

More on long-term responsiveness and effectiveness of renal denervation

TAVI: contemporary practice

21 May 2025 – From EuroPCR 2025

Stay updated on contemporary TAVI practices with insights from the 2024 European TAVI PATHWAY Registry. This session addresses comprehensive risk stratification in moderate aortic stenosis, safety and efficacy of repeat TAVI procedures, comparative outcomes of explant versus redo-TAVI after valve failure, and long-term neurological outcomes following...

TAVI: contemporary practice

LAA closure and anthrombotic therapies

21 May 2025 – From EuroPCR 2025

Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.

LAA closure and anthrombotic therapies

Intracoronary imaging for complex PCI: a must!

21 May 2025 – From EuroPCR 2025

Recognize the indispensable role of intracoronary imaging in managing complex PCI cases. This session explores the evolution of multivessel NSTEMI treatment using DES, BRS, DCB, and imaging, challenges with recurrent in-stent restenosis across multiple stent layers, innovative imaging solutions for complex lesions, and diagnostic approaches to...

Intracoronary imaging for complex PCI: a must!

Coronary scaffolds: new developments and applications

21 May 2025 – From EuroPCR 2025

Stay informed on advancements in coronary scaffolds with this session reviewing new developments and applications. Topics include comparative performance of magnesium-based bioresorbable stents, long-term clinical outcomes from the BIOMAG-I and FANTOM BRS studies, and real-world experiences with next-generation thin-strut scaffolds.

Coronary scaffolds: new developments and applications

Management of stent-related complications

21 May 2025 – From EuroPCR 2025

This session addresses the management of stent-related complications through a series of dramatic clinical cases. Learn methodical approaches to routine and crisis scenarios including primary PCI complications, failure to stent, and unexpected challenges encountered during interventions, highlighting practical bailout techniques and decision-making frameworks.

Management of stent-related complications

Mitral TEER in challenging scenarios - Part 2

21 May 2025 – From EuroPCR 2025

This session focuses on challenging scenarios encountered during mitral transcatheter edge-to-edge repair (TEER). Learn about management of complications such as haemolysis, device malfunctions, and complex vascular access issues, supported by instructive case presentations including bailout strategies in cardiogenic shock and infective endocarditis.

Mitral TEER in challenging scenarios - Part 2

TAV-in-TAV complications

21 May 2025 – From EuroPCR 2025

Focus on the complexities and challenges of TAV-in-TAV procedures in this session. Topics include planning valve-in-valve TAVI for aortic bioprosthetic valve regurgitation, managing anatomical challenges such as left ventricular outflow tract calcium and large annulus, and addressing severe bicuspid valve stenosis with impaired ventricular function. The...

TAV-in-TAV complications

Imaging-based strategies for complication management in STEMI

21 May 2025 – From EuroPCR 2025

Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.

Imaging-based strategies for complication management in STEMI

Iatrogenic causes for shock treated with LV support

21 May 2025 – From EuroPCR 2025

Explore the management of iatrogenic causes of cardiogenic shock requiring left ventricular support. This session presents complex cases including shock following Bentall procedures, complications during anesthesia induction in bypass surgery, and strategic approaches to prevent and manage these critical scenarios using LV support devices.

Iatrogenic causes for shock treated with LV support
Didn’t find what you were looking for?